MISSION Therapeutics Company
Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Number Of Exists:
N/A
Founded Date:
2011
Employee Number:
11-50
Investment Stage:
N/A
Investor Type:
N/A
Technology:
Cancer
Funding Status:
Late Stage Venture
Estimated Revenue:
$10M to $50M
Industry:
Mitochondrial Dynamics